These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1569406)

  • 21. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
    Bergerot I; Fabien N; Thivolet C
    Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice.
    Suarez-Pinzon WL; Mabley JG; Strynadka K; Power RF; Szabó C; Rabinovitch A
    J Autoimmun; 2001 Jun; 16(4):449-55. PubMed ID: 11437493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer.
    Clare-Salzler MJ; Brooks J; Chai A; Van Herle K; Anderson C
    J Clin Invest; 1992 Sep; 90(3):741-8. PubMed ID: 1522229
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice.
    Fox CJ; Danska JS
    J Immunol; 1997 Mar; 158(5):2414-24. PubMed ID: 9036992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin.
    Zhang ZJ; Davidson L; Eisenbarth G; Weiner HL
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10252-6. PubMed ID: 1946445
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
    Maki T; Ichikawa T; Blanco R; Porter J
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse.
    Wicker LS; Miller BJ; Coker LZ; McNally SE; Scott S; Mullen Y; Appel MC
    J Exp Med; 1987 Jun; 165(6):1639-54. PubMed ID: 3585250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
    Vaysburd M; Lock C; McDevitt H
    J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
    Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
    Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice.
    Itoh N; Imagawa A; Hanafusa T; Waguri M; Yamamoto K; Iwahashi H; Moriwaki M; Nakajima H; Miyagawa J; Namba M; Makino S; Nagata S; Kono N; Matsuzawa Y
    J Exp Med; 1997 Aug; 186(4):613-8. PubMed ID: 9254659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC; Power RF
    J Immunol; 1995 May; 154(9):4874-82. PubMed ID: 7722337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice.
    Arany E; Strutt B; Romanus P; Remacle C; Reusens B; Hill DJ
    Diabetologia; 2004 Oct; 47(10):1831-7. PubMed ID: 15502919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N; Minamimura K; Kodaka T; Maki T
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice.
    Gysemans CA; Cardozo AK; Callewaert H; Giulietti A; Hulshagen L; Bouillon R; Eizirik DL; Mathieu C
    Endocrinology; 2005 Apr; 146(4):1956-64. PubMed ID: 15637289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.
    Lenschow DJ; Ho SC; Sattar H; Rhee L; Gray G; Nabavi N; Herold KC; Bluestone JA
    J Exp Med; 1995 Mar; 181(3):1145-55. PubMed ID: 7532678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral administration of PDX1 confers protection against insulitis in the non-obese diabetic (NOD) mice.
    Lin P; Li W; Yao Z; Sun Y; Wang L; Li S; Chen L
    Biochem Biophys Res Commun; 2015 Oct; 466(4):656-63. PubMed ID: 26403969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyethylene glycolated recombinant TNF receptor I improves insulitis and reduces incidence of spontaneous and cyclophosphamide-accelerated diabetes in nonobese diabetic mice.
    Wang JL; Qian X; Chinookoswong N; Lu J; Chow G; Theill LE; Shi ZQ
    Endocrinology; 2002 Sep; 143(9):3490-7. PubMed ID: 12193562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AEB-071 has minimal impact on onset of autoimmune diabetes in NOD mice.
    Merani S; Edgar RL; Toso C; Emamaullee J; Thiesen A; Shapiro AM
    Autoimmunity; 2009 Mar; 42(3):242-8. PubMed ID: 19301207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.